Most recent by John Barbieri, MD, MBA
Triple combination CAB gel shows similar efficacy in males, females
Fixed-dose triple combination CAB gel showed efficacy in treating acne in both male and female patients aged 9 years and older, according to pooled data from two studies.
Study shows benzoyl peroxide products on store shelves may already contain benzene
A new study confirmed previous findings that acne products containing benzoyl peroxide have high levels of cancer-causing benzene which are not stabilized by encapsulation techniques even at room temperature.
To test or not to test: Isotretinoin marginally increases risk for severe adverse events
Isotretinoin is associated with a clinically marginal increased risk for severe adverse events, leading researchers to advise routine blood testing commence shortly after initiation, according to a study.
Beneath the Surface: A deep dive into iPledge changes with John Barbieri, MD
Beneath the Surface is a video series in which Joel M. Gelfand, MD, MSCE, Healio Dermatology Chief Medical Editor, discusses hot topics in the field with leading experts.
Beneath the Surface: Exploring spironolactone’s place in acne management
Beneath the Surface is a video series in which Joel M. Gelfand, MD, MSCE, Healio Dermatology Chief Medical Editor, discusses hot topics in the field with leading experts.
Beneath the Surface: Exploring the new AAD acne guidelines
Beneath the Surface is a video series in which Joel M. Gelfand, MD, MSCE, Healio Dermatology Chief Medical Editor, discusses hot topics in the field with leading experts.
Isotretinoin may not increase adverse mental health outcomes
Patients who take isotretinoin for severe acne did not show signs of adverse neuropsychiatric impacts compared with those who took antibiotics for acne, according to a study.